IDF Presentations

Wednesday, June 23

When will IVIG have SARS-CoV-2 antibodies in it? Use of hyper-immune serum or anti-COVID monoclonals to bridge the gap until we have IVIG with anti SARS-CoV-2 antibodies in it
Manish Butte, MD, PhD
University of California, Los Angeles

Experience with the COVID-19 Vaccine
Sara Anvari, MD, MSc, FAAAAI
Baylor College of Medicine/Texas Children's Hospital (Houston)

View Session Recording


Thursday, June 24

When should you refer your young adult patients to an Immunologist for a PIDD evaluation
Jennifer Heimall, MD
Children’s Hospital of Philadelphia

Lung disease in patients with PIDD, Diagnosis and Treatment
Ken Olivier, MD, MPH
National Heart, Lung, and Blood Institute


Friday, June 25

Antibiotic prophylaxis in PIDD
Daniel Dulek, MD
Vanderbilt Children’s Hospital

Use of immunomodulators to control immune dysregulation in PIDD/PIRD
Lisa Forbes-Satter, MD
Baylor College of Medicine